Atypical Hemolytic Uremic Syndrome (aHUS)
7 clinical trials · Condition
◉ Watch Atypical Hemolytic Uremic Syndrome (aHUS)
| Record | Firm | Date |
|---|---|---|
| Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS) (NCT03131219) | Alexion Pharmaceuticals, Inc. | 2017-08-31 |
| Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) (NCT02949128) | Alexion Pharmaceuticals, Inc. | 2017-01-11 |
| To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients (NCT01755429) | Alexion Pharmaceuticals, Inc. | 2012-05-01 |
| A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS) (NCT01770951) | Alexion Pharmaceuticals, Inc. | 2009-08-31 |
Track Atypical Hemolytic Uremic Syndrome (aHUS) automatically
Every clearance here is in the API, with alerts when new ones post.